Semaglutide’s cardiac benefits extend to people with heart failure
The anti-obesity medication semaglutide may help to prevent heart attacks and other major adverse cardiac events (MACE) among people...
top of page
Browse by category
Search
Semaglutide leads to greater weight loss in women than men with heart failure
Semaglutide significantly improves symptoms in men and women with a common type of heart failure that has had few therapeutic options....
Journal Watch 15/05/2024
Welcome to our weekly round-up of the latest bariatric and obesity-related papers published in the medical literature. As ever, we have...
Waist-to-height ratio is a better indicator of outcomes in patients with heart failure than BMI
New research has debunked the idea that there is an “obesity paradox”, whereby patients with heart failure who are overweight or obese...
'Healthy' people with obesity more likely to develop heart failure
Adults with obesity but who otherwise appear healthy without common metabolic abnormalities such as high blood pressure, abnormal blood...
Browse by tag
bottom of page